- Home
- SYRE vs HE Comparison
SYRE vs HE Comparison
Compare SYRE & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYRE | HE |
|---|---|---|
| Founded | 2013 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYRE | HE |
|---|---|---|
| Price | $34.16 | $17.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $56.50 | $12.67 |
| AVG Volume (30 Days) | 569.5K | ★ 3.3M |
| Earning Date | 02-26-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $3,080,252,000.00 |
| Revenue This Year | N/A | $12.61 |
| Revenue Next Year | N/A | $2.04 |
| P/E Ratio | ★ N/A | $196.73 |
| Revenue Growth | N/A | ★ 3.28 |
| 52 Week Low | $10.91 | $9.06 |
| 52 Week High | $35.31 | $17.09 |
Technical Indicators
Market Signals| Indicator | SYRE | HE |
|---|---|---|
| Relative Strength Index (RSI) | 57.61 | 74.96 |
| Support Level | $30.92 | $15.14 |
| Resistance Level | $34.07 | $16.67 |
| Average True Range (ATR) | 1.80 | 0.63 |
| MACD | -0.03 | 0.13 |
| Stochastic Oscillator | 78.41 | 96.38 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.